Mizuho Issues Positive Forecast for Welltower (NYSE:WELL) Stock Price

Welltower (NYSE:WELL) had its price target upped by Mizuho from $141.00 to $170.00 in a research note issued to investors on Tuesday,Benzinga reports. Mizuho currently has an outperform rating on the real estate investment trust’s stock.

Other research analysts have also recently issued research reports about the company. Raymond James lifted their price objective on Welltower from $145.00 to $155.00 and gave the company a “strong-buy” rating in a research note on Monday, December 16th. Royal Bank of Canada upgraded Welltower from a “sector perform” rating to an “outperform” rating and lifted their price objective for the company from $146.00 to $168.00 in a research note on Friday, February 28th. Bank of America lifted their price objective on Welltower from $221.00 to $242.00 and gave the company a “buy” rating in a research note on Tuesday, February 18th. Wells Fargo & Company boosted their price target on Welltower from $140.00 to $158.00 and gave the stock an “equal weight” rating in a research note on Monday, March 10th. Finally, Scotiabank boosted their price target on Welltower from $165.00 to $166.00 and gave the stock a “sector outperform” rating in a research note on Thursday, March 6th. Three equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Welltower has a consensus rating of “Moderate Buy” and a consensus target price of $156.46.

Welltower Trading Down 0.9 %

WELL opened at $149.92 on Tuesday. The stock has a market cap of $96.14 billion, a PE ratio of 96.10, a PEG ratio of 2.87 and a beta of 1.20. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.48. The business has a 50 day moving average of $142.19 and a 200-day moving average of $134.25. Welltower has a 52 week low of $87.87 and a 52 week high of $158.55.

Welltower (NYSE:WELL) last released its earnings results on Tuesday, February 11th. The real estate investment trust reported $1.13 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.73. Welltower had a return on equity of 3.15% and a net margin of 11.91%. Equities research analysts predict that Welltower will post 4.88 earnings per share for the current fiscal year.

Welltower Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 6th. Investors of record on Tuesday, February 25th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 1.79%. The ex-dividend date of this dividend was Tuesday, February 25th. Welltower’s payout ratio is currently 171.79%.

Institutional Trading of Welltower

Large investors have recently modified their holdings of the company. Laurel Wealth Advisors LLC bought a new stake in shares of Welltower in the fourth quarter worth $25,000. Roxbury Financial LLC bought a new stake in Welltower during the fourth quarter valued at about $26,000. Sierra Ocean LLC bought a new stake in Welltower during the fourth quarter valued at about $28,000. Versant Capital Management Inc grew its holdings in Welltower by 165.5% during the fourth quarter. Versant Capital Management Inc now owns 300 shares of the real estate investment trust’s stock valued at $38,000 after purchasing an additional 187 shares during the period. Finally, First Command Advisory Services Inc. bought a new stake in Welltower during the fourth quarter valued at about $50,000. Institutional investors own 94.80% of the company’s stock.

Welltower Company Profile

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.